will neoadjuvant targeted therapies play a role in nsclc?
Published 1 year ago • 64 plays • Length 1:16Download video MP4
Download video MP3
Similar videos
-
2:28
clinical trials of neoadjuvant targeted therapy in resectable nsclc
-
3:44
immunotherapy as combination and neoadjuvant therapies in nsclc
-
2:51
neoadjuvant treatment for patients with nsclc - targeted therapies in lung cancer 2023
-
1:25
neoadjuvant therapy is taking off in lung cancer
-
4:08
targeted therapies in lung cancer
-
6:57
updates in lung cancer: neoadjuvant immunotherapy and targeted therapies
-
0:56
nautika1: safety and tolerability of neoadjuvant alectinib in alk-positive nsclc
-
1:24
optimizing neoadjuvant therapy in nsclc with biomarker research
-
1:18
exploring neoadjuvant egfr-tkis in lung cancer
-
3:02
neoadjuvant and adjuvant immunotherapy in non-small cell lung cancer
-
2:31
differences in treating lung cancer with adjuvant and neoadjuvant immunotherapy
-
2:20
selecting patients with nsclc who benefit from immunotherapy or targeted therapies
-
1:31
squat: neoadjuvant chemo-immuno-radiation and surgery in nsclc
-
2:15
the impact of durvalumab for resectable non-small cell lung cancer
-
1:04
does neoadjuvant chemotherapy have a role in resectable pancreatic cancer?
-
2:03
improving outcomes in nsclc with perioperative targeted therapies
-
5:59
targeted therapy in consolidation setting for lung cancer
-
3:41
targeted therapy versus standards of care in metastatic nsclc
-
1:51
future directions for neoadjuvant immunotherapy in lung cancer